PSYCHEDELICS WORLDWIDE: DIFFICULT EXPERIENCES ('BAD TRIPS'), MICRO-DOSING AND CEREMONIAL USE
The Global Drug Survey is an independent anonymous web survey of people who use drugs. The goal of GDS is to make drug use safer, regardless of the legal status of the drug. In 2017, we included a new section for users of psychedelics. We covered (1) difficult or negative experiences, (2) micro-dosing and performance enhancement, and (3) ceremonial use of psychedelics with shamans/healers. Over 5000 people completed this section of the survey. In this presentation, I will present findings from the survey of these three topics. The presentation will answer questions that include Which psychedelics are associated with the most and least negative experiences? What characteristics of psychedelic users are associated with reporting negative experiences? When are 'negative experiences' perceived as 'bad trips' or not? How do people most commonly manage negative experiences from psychedelics? Who is most likely to report microdosing with psychedelics, and with which kinds of psychedelics? What are the perceived impacts of microdosing? Who is more likely to report engaging in ceremonial psychedelic use? In which countries and with which psychedelics? What are the motivations for engaging in ceremonial psychedelic use? What are the key motivations for psychedelic use over the lifetime? Do people tell their family and friends about their psychedelic use, and if not, what are the fears that prevent disclosure?
DR MONICA BARRATT is a social scientist at the Drug Policy Modelling Program, part of Australia's National Drug and Alcohol Research Centre at the University of New South Wales. Monica's work examines the social and public health implications of digital technologies for people who use illicit and emerging psychoactive drugs. Research topics emerging from this interest include online drug markets or cryptomarkets and policy responses to novel psychoactive substance evolution. She specialises in engaging hard-to-reach networks and groups in digital spaces in conversations about research and policy, to inform policy change. Monica also serves as an Editor for policy-related articles at the International Journal of Drug Policy, and as the Director of Research at the international drug harm reduction community Bluelight.org. Monica is a lead researcher for the Global Drug Survey. She is also a regular attendee and contributor to EGA, from the mid-2000s.